HydRegen raises funds for cell-free hydrogenase
Enzymes are powerful tools for chemical synthesis, but their natural setting within a microbe’s metabolism can limit…
Nuclide Therapeutics builds leaner radiopharmaceuticals
At a glance Publicly launched: 2024 Headquarters: London Technology: Small-molecule therapeutics and diagnostics containing radioactive halogen isotopes…
A new book shows how the country’s start-ups identified uniquely Indian demands and fulfilled them
In 2017, a young analyst like me didn’t have the luxury of being dispassionate about cycles or the…
One year after a bipolar episode, Bonobos cofounder sold his company to Walmart for $310 million
Over the course of his two-decade career, entrepreneur Andy Dunn has launched several businesses and invested in dozens…
Kura Oncology launches diabetes-focused Caspian Therapeutics
Just under a year after netting its first US approval for a cancer-fighting menin inhibitor, Kura Oncology…
Lydian raises $43 million for sustainable jet fuel
Sustainable aviation fuel (SAF) is developing rapidly within an uneven business environment around cleantech as a whole. Despite…
The Best Cities For Entrepreneurs to Start a Business, According to This Banking Pro
Shaolee Sen gets hit up for startup advice a lot. She grew up watching her mom build a…
Opinion | The Hunt for a Job Has Never Been Worse. These Applicants Are Fighting Back.
I recently wrote about the purgatory job market of 2026, in which potential employees are largely evaluated by…
Investor won’t back startups unless staff are in the office 6 days a week ‘because they’re going to fail’
For years, business leaders from Jamie Dimon to Elon Musk have predicted that AI could usher in shorter…
E Squared poured R300m into local start-ups in 2025
Story audio is generated using AI Local venture capital firm E Squared Investments says it invested more than…
Opinion | A.I. Is Strangling Our Economy
We are witnessing one of the largest peacetime mobilizations of capital in modern American history. Topping $1 trillion…
How Haya Therapeutics is targeting the dark genome to treat fibrotic disease
AT A GLANCE Publicly launched: 2021 Headquarters: Lausanne, Switzerland, and San Diego Focus: Precision RNA-guided therapeutics targeting…